Empirical EUA Statement
The QuantiTASE Plus One Step RT-qPCR SARs-CoV-2 assay kit is available for In Vitro Diagnostic (IVD) use in accordance with the May 11 2020 FDA guidance document titled: Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised)
Click here for details.
QuantiTASE Two-Step Reagent RT-qPCR Kits contain all the supplemental components necessary to perform first strand cDNA synthesis with high sensitivity and efficiency from any RNA sample using two-step RT-qPCR protocols.
This kit is designed to be used in conjunction with Empirical’s RTScriptTM Transcriptase Enzymes or QuantiSCRIPT RT-qPCR Kits.
Empirical’s QuantiTASETM and QuantiTASE PLUS Universal RT-qPCR Kit solutions offer sensitivity and specificity and are capable of synthesizing highly structured and long cDNA fragments.
Produced cDNA is appropriate for qPCR analysis. The QuantiTASE Universal RT-qPCR Kits contain the reagents necessary to support most available equipment and protocols.